Topics

Biofourmis Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

13:52 EDT 4 Oct 2019 | HIT Consultants

– Biofourmis received 510(k) clearance from the FDA for its Analytics Engine as a medical device for ambulatory physiological monitoring. – Milestone approval establishes an AI-powered solution as the foundation for future disease-specific predictive management tools from Biofourmis. – This FDA approval is the second market authorization for Biofourmis, having earned the agency’s approval in ... Read More

Original Article: Biofourmis Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

NEXT ARTICLE

More From BioPortfolio on "Biofourmis Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring"

Quick Search

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...